News:Guoxin Technology: shareholders such as the National Fund intend to reduce their holdings by no more than 3%;Second, Contemporary Amperex Technology Co., Limited's enlargement trick: special dividends for factories in Europe
First, heavy! Shanghai merger and reorganization action plan announcedAmong them, the biggest benefit is the biomedical industry. It is necessary to set up a M&A fund with a scale of 10 billion, which is specifically aimed at the merger and reorganization of the biomedical industry! The focus is on local enterprises in Shanghai, especially the biomedicine of listed companies in Shanghai.Shanghai builds a merger and reorganization head company, and Ning Wang magnifies the move. The bull market still needs to be believed.
True Vision: The controlling shareholder and others intend to reduce their holdings by 4% in total;Easy to change the world: shareholders intend to reduce their holdings by no more than 3.05% in total;Second, Contemporary Amperex Technology Co., Limited's enlargement trick: special dividends for factories in Europe
Strategy guide 12-14
Strategy guide 12-14